Larson Yi 4
4 · Olema Pharmaceuticals, Inc. · Filed Jun 23, 2026
Research Summary
AI-generated summary of this filing
Olema (OLMA) Director Larson Yi Receives Stock Award
What Happened
- Director Larson Yi received a grant/award reported as a derivative covering 29,500 shares on June 18, 2026. The filing lists an acquisition price of $0.00 and a reported total value of $0.00 for the transaction. This was an award (not an open-market purchase or sale).
Key Details
- Transaction date: 2026-06-18; Report filed: 2026-06-23 (filed late — transactionTimeliness = 'L').
- Reported terms: 29,500 shares acquired as a derivative instrument, price reported $0.00, total reported value $0.00.
- Vesting: Shares subject to the option vest in 12 equal monthly installments starting June 18, 2026; any unvested portion vests in full on the issuer's next annual meeting if not fully vested earlier (subject to continued service). (Footnote F1)
- Shares owned after transaction: not specified in the provided excerpt of the filing.
- Type of transaction code: A (Grant/Award/Other Acquisition); not an exercise or sale.
Context
- This was a grant of a derivative award (an option-type award per the footnote), not a cash purchase or sale. There was no immediate exercise or sale reported. For retail investors, grants indicate company compensation to insiders but do not necessarily signal buying or selling intent; the vesting schedule ties value realization to continued service and/or the next annual meeting.
Insider Transaction Report
Form 4
Larson Yi
Director
Transactions
- Award
Stock Option (right to buy)
[F1]2026-06-18+29,500→ 29,500 totalExercise: $9.51Exp: 2036-06-18→ Common Stock (29,500 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest in a series of 12 successive equal monthly installments measured from June 18, 2026, subject to the Reporting Person's continuous service through each applicable vesting date. Such shares vest in full on the date of the Issuer's next annual meeting of stockholders if such stock option is not otherwise fully vested by such date, subject to the Reporting Person's continuous service through such vesting date.
Signature
/s/ Shawnte Mitchell, Attorney-in-Fact|2026-06-23